Cecilia Frej

A Shift in ApoM / S 1 P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM / S 1 P Complex

B. Dahlbäck, R. Goldberg, Cecilia Frej, 2017 .

A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex

B. Dahlbäck, R. Goldberg, Cecilia Frej, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation

B. Dahlbäck, Cecilia Frej, A. Andersson, 2015, Analytical and Bioanalytical Chemistry.

Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure

D. Rader, B. French, D. Mann, 2020, Circulation.

High‐density lipoprotein from end‐stage renal disease patients exhibits superior cardioprotection and increase in sphingosine‐1‐phosphate

B. Dahlbäck, Cecilia Frej, Estelle Lauer, 2018, European journal of clinical investigation.

Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus

C. Langefeld, J. Divers, D. Bowden, 2019, Journal of Lipid Research.

High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1

B. Dahlbäck, Cecilia Frej, Mario Ruiz, 2017, Arteriosclerosis, thrombosis, and vascular biology.

The ApoM/S1P-complex: its role in vascular inflammatory disease and interaction with S1P-receptors

Cecilia Frej, 2016 .

Sphingosine 1‐phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons

B. Dahlbäck, Cecilia Frej, F. Taylor, 2016, Journal of cellular and molecular medicine.